Aarti Pharmalabs Limited (AARTIPHARM)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 485.06 458.36 439.80 448.69 505.77 555.49 458.03 537.78 563.78 386.19 418.33 432.27
YOY Revenue Growth % - - - - 4.27% 21.19% 4.14% 19.86% 11.47% -30.48% -8.67% -19.62%
Other Income 0.74 0.48 0.98 1.39 2.03 2.22 4.48 5.03 -1.61 1.60 0.05 -0.37
Total Income 485.80 458.84 440.78 450.08 507.80 557.71 462.51 542.81 562.17 387.79 418.39 431.90
Total Expenses + 337.06 322.64 321.44 323.54 336.66 340.60 349.35 395.05 447.55 320.54 379.05 371.16
Cost of Materials Consumed 226.99 220.07 221.89 214.96 201.52 219.81 220.58 261.19 185.45 191.42 203.46 209.42
Employee Benefit Expense 33.22 33.25 31.60 36.16 37.40 39.23 37.73 41.63 43.37 41.26 43.41 43.38
Other Expenses 76.85 69.32 67.95 72.43 97.73 81.56 91.05 92.23 96.03 80.29 90.43 113.93
Operating Profit 148.00 135.72 118.36 125.14 169.11 214.90 108.67 142.73 116.23 65.66 39.28 61.11
OPM % 30.5% 29.6% 26.9% 27.9% 33.4% 38.7% 23.7% 26.5% 20.6% 17% 9.4% 14.1%
Profit Before Tax + 58.84 63.98 66.95 73.82 95.75 73.68 71.77 100.63 114.62 67.25 39.33 57.95
Tax Expense 15.97 16.89 15.15 21.06 30.50 18.22 17.15 26.64 26.28 17.75 11.41 9.99
Tax % 27.1% 26.4% 22.6% 28.5% 31.9% 24.7% 23.9% 26.5% 22.9% 26.4% 29% 17.2%
Profit After Tax 42.87 47.09 51.80 52.76 65.25 55.45 54.62 73.99 88.34 49.50 27.92 47.96
EPS (Basic) 4.73 5.20 5.72 5.82 7.20 6.12 6.03 8.16 9.75 5.46 3.08 5.29

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 2,115.07 1,852.61 1,945.23
YOY Revenue Growth % 14.17% -4.76% -
Other Income 10.12 4.90 2.32
Total Income 2,125.19 1,857.50 1,947.55
Total Expenses + 1,764.50 1,304.29 1,447.73
Cost of Materials Consumed 887.02 858.45 1,014.30
Employee Benefit Expense 161.96 138.41 129.69
Other Expenses 360.87 307.44 303.74
Operating Profit 350.57 548.31 497.50
OPM % 16.6% 29.6% 25.6%
Profit Before Exceptional 360.69 300.49 260.77
Exceptional Items 0.00 0.00 0.00
Profit Before Tax + 360.69 300.49 260.77
Tax Expense 88.28 83.59 67.28
Tax % 24.5% 27.8% 25.8%
Profit After Tax 272.40 216.90 193.49
EPS (Basic) 30.06 23.93 21.35

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 1,584.24 1,236.46 1,075.17
Property, Plant & Equipment 1,104.12 1,014.69 922.74
Capital Work in Progress 306.58 78.50 62.20
Non-Current Investments 29.24 0.00 35.52
Goodwill 1.78 1.78 1.78
Other Intangible Assets 30.67 16.85 1.32
Current Assets + 1,322.17 1,345.64 1,155.76
Inventories 587.58 642.86 602.04
Trade Receivables 575.40 519.34 440.05
Cash and Cash Equivalents 6.73 23.63 24.93
Current Investments 47.56 70.39 38.18
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00
Equity Share Capital 45.32 45.31 45.31
Other Equity 1,944.59 1,711.73 1,513.17
Non-Current Liabilities 259.45 130.68 80.87
Current Liabilities 657.05 694.38 591.58
Total Liabilities 916.50 825.06 672.45

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities 331.56 216.36 263.00
Cash from Investing Activities -413.90 -214.57 -157.80
Cash from Financing Activities 65.44 9.72 -163.47
Net Increase/Decrease in Cash -16.90 11.51 -58.27